These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 30184238)

  • 1. Proteinuria and cholesterol reduction are independently associated with less renal function decline in statin-treated patients; a post hoc analysis of the PLANET trials.
    Idzerda NMA; Pena MJ; Parving HH; de Zeeuw D; Heerspink HJL
    Nephrol Dial Transplant; 2019 Oct; 34(10):1699-1706. PubMed ID: 30184238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between individual cholesterol and proteinuria response and exposure to atorvastatin or rosuvastatin.
    Kroonen MYAM; Stevens J; de Zeeuw D; Heerspink HJL
    Diabetes Obes Metab; 2019 Dec; 21(12):2635-2642. PubMed ID: 31414562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal effects of atorvastatin and rosuvastatin in patients with diabetes who have progressive renal disease (PLANET I): a randomised clinical trial.
    de Zeeuw D; Anzalone DA; Cain VA; Cressman MD; Heerspink HJ; Molitoris BA; Monyak JT; Parving HH; Remuzzi G; Sowers JR; Vidt DG
    Lancet Diabetes Endocrinol; 2015 Mar; 3(3):181-90. PubMed ID: 25660356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of high-dose atorvastatin on renal function in subjects with stroke or transient ischemic attack in the SPARCL trial.
    Amarenco P; Callahan A; Campese VM; Goldstein LB; Hennerici MG; Messig M; Sillesen H; Welch KM; Wilson DJ; Zivin JA
    Stroke; 2014 Oct; 45(10):2974-82. PubMed ID: 25147328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of High-Density Lipoprotein Cholesterol With Renal Function in Patients Treated With Atorvastatin.
    Ong KL; Waters DD; Fayyad R; Vogt L; Melamed S; DeMicco DA; Rye KA; Barter PJ
    J Am Heart Assoc; 2018 Jan; 7(2):. PubMed ID: 29358194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The proteinuria-lowering effects of dapagliflozin are associated with an initial decline in estimated glomerular filtration rate in patients with chronic kidney disease.
    Murakoshi M; Kobayashi T; Kihara M; Ueda S; Suzuki Y; Gohda T
    Nephrology (Carlton); 2023 Oct; 28(10):540-547. PubMed ID: 37357381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of different types of statins on kidney function decline and proteinuria: a network meta-analysis.
    Esmeijer K; Dekkers OM; de Fijter JW; Dekker FW; Hoogeveen EK
    Sci Rep; 2019 Nov; 9(1):16632. PubMed ID: 31719617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal assessment of estimated glomerular filtration rate in apparently healthy adults: a post hoc analysis from the JUPITER study (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin).
    Vidt DG; Ridker PM; Monyak JT; Schreiber MJ; Cressman MD
    Clin Ther; 2011 Jun; 33(6):717-25. PubMed ID: 21704236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of atorvastatin and rosuvastatin on renal function: a meta-analysis.
    Savarese G; Musella F; Volpe M; Paneni F; Perrone-Filardi P
    Int J Cardiol; 2013 Sep; 167(6):2482-9. PubMed ID: 22633671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction and residual proteinuria are therapeutic targets in type 2 diabetes with overt nephropathy: a post hoc analysis (ORIENT-proteinuria).
    Imai E; Haneda M; Chan JC; Yamasaki T; Kobayashi F; Ito S; Makino H
    Nephrol Dial Transplant; 2013 Oct; 28(10):2526-34. PubMed ID: 24013685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Statins on Renal Outcome in Chronic Kidney Disease Patients: A Systematic Review and Meta-Analysis.
    Sanguankeo A; Upala S; Cheungpasitporn W; Ungprasert P; Knight EL
    PLoS One; 2015; 10(7):e0132970. PubMed ID: 26151753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Statins on Kidney Disease Outcomes: A Systematic Review and Meta-analysis.
    Su X; Zhang L; Lv J; Wang J; Hou W; Xie X; Zhang H
    Am J Kidney Dis; 2016 Jun; 67(6):881-92. PubMed ID: 26905361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins can improve proteinuria and glomerular filtration rate loss in chronic kidney disease patients, further reducing cardiovascular risk. Fact or fiction?
    Athyros VG; Katsiki N; Karagiannis A; Mikhailidis DP
    Expert Opin Pharmacother; 2015; 16(10):1449-61. PubMed ID: 26037614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins for improving renal outcomes: a meta-analysis.
    Sandhu S; Wiebe N; Fried LF; Tonelli M
    J Am Soc Nephrol; 2006 Jul; 17(7):2006-16. PubMed ID: 16762986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of rosuvastatin and atorvastatin on renal function: meta-analysis.
    Wu Y; Wang Y; An C; Dong Z; Liu H; Zhang Y; Zhang M; An F
    Circ J; 2012; 76(5):1259-66. PubMed ID: 22382383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement in Renal Function and Reduction in Serum Uric Acid with Intensive Statin Therapy in Older Patients: A Post Hoc Analysis of the SAGE Trial.
    Deedwania PC; Stone PH; Fayyad RS; Laskey RE; Wilson DJ
    Drugs Aging; 2015 Dec; 32(12):1055-65. PubMed ID: 26625880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
    Strandberg TE; Feely J; Sigurdsson EL;
    Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation Between Change in Renal Function and Cardiovascular Outcomes in Atorvastatin-Treated Patients (from the Treating to New Targets [TNT] Study).
    Shepherd J; Breazna A; Deedwania PC; LaRosa JC; Wenger NK; Messig M; Wilson DJ;
    Am J Cardiol; 2016 Apr; 117(8):1199-205. PubMed ID: 26940556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Statin Use With Kidney Damage and Function Among HIV-Infected Men.
    Ascher SB; Scherzer R; Nishtala A; Jotwani V; Grunfeld C; Parikh CR; Ng D; Wang R; Palella FJ; Shlipak MG; Estrella MM
    J Acquir Immune Defic Syndr; 2019 Oct; 82(2):202-210. PubMed ID: 31356467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of short-term rosuvastatin treatment on estimated glomerular filtration rate.
    Vidt DG; Harris S; McTaggart F; Ditmarsch M; Sager PT; Sorof JM
    Am J Cardiol; 2006 Jun; 97(11):1602-6. PubMed ID: 16728222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.